Fresh Recalls

FDAClass II · Drug · Recall D-0493-2026 · Recalled April 29, 2026

Omega-3-Acid recall — The Harvard Drug Group LLC

Agency report date: April 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Omega-3-Acid
Company / brand
The Harvard Drug Group
Lot / serial / date codes
Lot#: Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026
Distribution
Nationwide in the USA
Agency product description and boundaries

Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46288. NDC: 0904-7495-06

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Omega-3-Acid

3. Open the official notice or contact

Official recall ID
D-0493-2026
Brand
The Harvard Drug Group
Classification
Class II
Units affected
2,238 5 x 10 unit dose cartons
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Dublin, OH, United States
Firm address
7000 Cardinal Pl, N/A, 43017-1091

Identifying details (verbatim from the notice)

Product codes / lots
Lot#: Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
98763
Recall initiated
April 9, 2026
FDA classified
April 24, 2026
FDA report date
April 29, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved July 28, 2026 at 11:00 PM UTC.

Report a data error on this page